在日本提交药品营销许可证的良好实验室实践研究的趋势
1Pharmaceuticals and Medical Devices Agency, Tokyo, Japan.
Frontiers in pharmacology
|July 21, 2025
概括
提交给日本药品和医疗器械局 (PMDA) 的良好实验室实践 (GLP) 研究趋势显示,国内提交的申请减少,来自中国和台湾的申请增加. 这反映了全球药物开发和监管方面的转变.
科学领域:
- 药物监督和监管科学 药物监督和监管科学
- 药物开发和批准过程 药物开发和批准过程
- 全球卫生政策 全球卫生政策
背景情况:
- 制药和医疗器械管理局 (PMDA) 要求符合良好实验室实践 (GLP) 的非临床安全研究获得医疗产品营销许可.
- 了解这些GLP研究中的趋势对于评估全球药物开发格局和监管遵守至关重要.
研究的目的:
- 分析2017财年至2023财年向PMDA提交的符合GLP的非临床研究的趋势.
- 调查研究起源的地理转移及其对药物开发时间表和监管政策的影响.
主要方法:
- 对PMDA提交的符合GLP的非临床研究提交的趋势分析.
- 研究起源的地理分析.研究起源的地理分析.
- 分析研究完成和提交之间的时间间隔.
主要成果:
- 在分析期间,向PMDA提交的日本GLP研究比例略有下降.
- 来自中国和台湾的新兴研究趋势,表明这些地区的药物开发活动增加.
- 证据表明日本可能存在"药物滞后"或"药物损失",得到提交时间分析的支持.
结论:
- 这些发现表明全球制药研发的转变,中国和台湾的贡献越来越大.
- 关于非经合组织数据相互接受 (MAD) 国家的GLP研究,PMDA的政策需要进一步讨论和调整.
- 这些趋势凸显了国际药物开发和监管协调的不断变化的动态.
关键词:
经济合作与发展组织 (OECD)良好的实验室实践 (GLP)数据的相互接受 (MAD)非MAD国家国家.非临床安全研究非临床安全研究药品制品制品制品制品制品制品制品制品再生医疗产品的再生医疗产品更多相关视频
09:55Radiosynthesis, Quality Control, and Small Animal Positron Emission Tomography Imaging of 68Ga-Labelled Nano Molecules
Published on: October 4, 2024
544
07:43Author Spotlight: Addressing Regulatory Gaps in Molecular Studies by Quantifying Viral Vectors in Complex Matrices
Published on: July 14, 2023
2.4K
相关概念视频
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
177
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
177
Drug Regulation
1.9K
Drug regulation encompasses the management of drug usage by evaluating its safety and efficacy through assessments conducted by regulatory authorities. Regrettably, the history of drug regulation is marred by several catastrophic events. One such incident is the Elixir Sulfanilamide tragedy, in which the toxic compound diethyl glycol was included in a sweet-tasting medication, leading to numerous fatalities. This event prompted the enactment of the Food, Drug, and Cosmetic Act in 1938. Under...
1.9K
Clinical Trials: Overview
3.4K
Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
3.4K
Clinical Trials
8.5K
Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
There are four phases in a clinical trial. A phase one...
There are four phases in a clinical trial. A phase one...
8.5K
Pharmacovigilance
996
Post-marketing surveillance is a critical component of pharmaceutical regulation, often uncovering unanticipated adverse drug reactions (ADRs) once a drug is widely used over an extended period.
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
996
Preclinical Development: Overview
4.8K
Preclinical development consists of a series of tests that ensure the safety and efficacy of a new therapeutic compound before it is tested in humans. There are four main phases to this process. First, safety pharmacology tests are conducted to ensure the drug does not produce any acutely harmful effects. These tests examine parameters such as bronchoconstriction, cardiac dysrhythmias, blood pressure changes, and ataxia. Next, preliminary toxicological testing is performed to determine the...
4.8K
